5 December 2017Americas
SCOTUS rejects Dow’s $455m appeal against Bayer
The US Supreme Court has refused to rule on a patent dispute between agricultural companies Dow AgroSciences and Bayer CropScience.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
15 September 2017 Agriculture company Dow has asked the US Supreme Court to review a dispute centring on damages for infringement of patents related to genetically engineered soybeans.
Americas
15 May 2017 The US Court of Appeals for the Federal Circuit has rejected Dow Agro Sciences’ petition for a rehearing of the court’s March decision which affirmed a $455 million damages award in favour of Bayer.
Editor's picks
Editor's picks
Americas
15 September 2017 Agriculture company Dow has asked the US Supreme Court to review a dispute centring on damages for infringement of patents related to genetically engineered soybeans.
Americas
15 May 2017 The US Court of Appeals for the Federal Circuit has rejected Dow Agro Sciences’ petition for a rehearing of the court’s March decision which affirmed a $455 million damages award in favour of Bayer.
Americas
15 September 2017 Agriculture company Dow has asked the US Supreme Court to review a dispute centring on damages for infringement of patents related to genetically engineered soybeans.
Americas
15 May 2017 The US Court of Appeals for the Federal Circuit has rejected Dow Agro Sciences’ petition for a rehearing of the court’s March decision which affirmed a $455 million damages award in favour of Bayer.